No photo of Aaron LeBeau
Contact Expert

View Scopus Profile

Aaron LeBeau

20052020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Function and Clinical Utility of the HOXB13 Co-Factors MEIS1 and MEIS2 in Prostate Cancer Progression

LeBeau, A.

UNIV OF ILLINOIS CHICAGO

1/1/20 → 12/31/20

Project: Research project

    • Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer

    LeBeau, A. & Li, F.

    NIH NATIONAL CANCER INSTITUTE (NCI)

    1/1/20 → 12/31/24

    Project: Research project

    • CD133-Targeted Natural Killer Cell Therapy for Aggressive Prostate Cancer

    LeBeau, A. & Moriarity, B. S.

    U.S. DEPARTMENT OF DEFENSE

    8/1/19 → 7/31/22

    Project: Research project

    • Novel Radioimmunotherapy Strategies for Prostate Cancer

    LeBeau, A. & Murugan, P.

    NIH NATIONAL CANCER INSTITUTE (NCI)

    7/1/19 → 6/30/24

    Project: Research project

    Targeting CD133 for imaging and therapy in prostate cancer

    LeBeau, A., Jallow, N. & Murugan, P.

    NIH NATIONAL CANCER INSTITUTE (NCI)

    7/1/19 → 6/30/24

    Project: Research project

    • Research Output

    Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer

    Glumac, P. M., Gallant, J. P., Shapovalova, M., Li, Y., Murugan, P., Gupta, S., Coleman, I. M., Nelson, P. S., Dehm, S. M. & Lebeau, A. M., Mar 1 2020, In : Clinical Cancer Research. 26, 5, p. 1054-1064

    Research output: Contribution to journal › Article

    Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography

    Hintz, H. M., Gallant, J. P., Vander Griend, D. J., Coleman, I. M., Nelson, P. S. & Lebeau, A. M., Jul 7 2020, In : Clinical Cancer Research.

    Research output: Contribution to journal › Article

    Correction: Exploiting the transcriptional specificity of the alphamethylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer (Oncotarget (2018) 9 (36693-36704) DOI: 10.18632/oncotarget.26401)

    Shapovalova, M., Davydova, J., Henzler, C., Daniel, M., Dehm, S. M., Warlick, C. A. & LeBeau, A. M., Aug 1 2019, In : Oncotarget. 10, 47, 1 p.

    Research output: Contribution to journal › Comment/debate

    Open Access

    • Development of a cross-reactive monoclonal antibody for detecting the tumor stroma

    Hintz, H. M., Cowan, A. E., Shapovalova, M. & LeBeau, A., May 15 2019, In : Bioconjugate Chemistry. 30, 5, p. 1466-1476 11 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    PEG10 promoter-driven expression of reporter genes enables molecular imaging of lethal prostate cancer

    Shapovalova, M., Lee, J. K., Li, Y., Griend, D. J. V., Coleman, I. M., Nelson, P. S., Dehm, S. M. & LeBeau, A. M., Nov 1 2019, In : Cancer Research. 79, 21, p. 5668-5680 13 p.

    Research output: Contribution to journal › Article